shanghai synergy pharmaceutical sciences co.,ltd.was established in August 2015 with a registered capital of 70 million yuan. It is a wholly-owned subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd. The company is located in the core park of Zhangjiang Hi-Tech Park, Zhangjiang High-tech Industrial Development Zone, the National Shanghai Biomedicine Technology Industry Base. Carry out the research and development of small molecule chemical innovative drugs, mainly involving the fields of cardiovascular and cerebrovascular, central nervous system, and tumors.

As the R&D center for innovative drugs of Zhejiang Huahai Pharmaceutical Co., Ltd., the company currently has a complete R&D system, senior scientific researchers, a complete new drug R&D evaluation system, and an efficient innovation team. High-level scientific research has been carried out for independent R&D projects and In-License projects. The company aims to reach the leading domestic level in the R&D of innovative drugs by 2025, and realize the upgrading and transformation of Zhejiang Huahai Pharmaceutical Co., Ltd. into a leading domestic innovative drug R&D enterprise, and form Huahai advantages in the fields of central nervous system, cardiovascular and cerebrovascular, tumors, immunity, and metabolism.